134 related articles for article (PubMed ID: 22947063)
1. Structural rearrangements at physiological pH: nuclear magnetic resonance insights from the V210I human prion protein mutant.
Biljan I; Ilc G; Giachin G; Plavec J; Legname G
Biochemistry; 2012 Sep; 51(38):7465-74. PubMed ID: 22947063
[TBL] [Abstract][Full Text] [Related]
2. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
3. NMR structural studies of human cellular prion proteins.
Biljan I; Ilc G; Giachin G; Legname G; Plavec J
Curr Top Med Chem; 2013; 13(19):2407-18. PubMed ID: 24059340
[TBL] [Abstract][Full Text] [Related]
4. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
5. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
Rossetti G; Giachin G; Legname G; Carloni P
Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.
Biljan I; Giachin G; Ilc G; Zhukov I; Plavec J; Legname G
Biochem J; 2012 Sep; 446(2):243-51. PubMed ID: 22676969
[TBL] [Abstract][Full Text] [Related]
7. NMR structure of the mouse prion protein domain PrP(121-231).
Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
[TBL] [Abstract][Full Text] [Related]
8. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
Avbelj M; Hafner-Bratkovič I; Jerala R
Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
[TBL] [Abstract][Full Text] [Related]
9. Detailed computational analysis revealed mutation V210I on PrP induced conformational conversion on β2-α2 loop and α2-α3.
Chandrasekaran P; Rajasekaran R
Mol Biosyst; 2016 Oct; 12(10):3223-33. PubMed ID: 27523988
[TBL] [Abstract][Full Text] [Related]
10. Monitoring prion protein stability by NMR.
Julien O; Graether SP; Sykes BD
J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
[TBL] [Abstract][Full Text] [Related]
11. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
Dima RI; Thirumalai D
Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
[TBL] [Abstract][Full Text] [Related]
12. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
13. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
14. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
16. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
17. Rare large scale subdomain motions in prion protein can initiate aggregation.
Schwarzinger S; Horn AH; Ziegler J; Sticht H
J Biomol Struct Dyn; 2006 Jun; 23(6):581-90. PubMed ID: 16615804
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the effect of glycosylation on human prion protein by molecular dynamics.
Zhong L; Xie J
J Biomol Struct Dyn; 2009 Apr; 26(5):525-33. PubMed ID: 19236103
[TBL] [Abstract][Full Text] [Related]
19. Conformational polymorphism of wild-type and mutant prion proteins: Energy landscape analysis.
Levy Y; Becker OM
Proteins; 2002 Jun; 47(4):458-68. PubMed ID: 12001224
[TBL] [Abstract][Full Text] [Related]
20. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
